HomeInsightsStock Comparison

Mangalam Drugs And Organics Ltd vs Medicamen Biotech Ltd Stock Comparison

Mangalam Drugs And Organics Ltd vs Medicamen Biotech Ltd Stock Comparison

Last Updated on: Jul 20, 2025

Key Highlights

  • The Latest Trading Price of Mangalam Drugs and Organics Ltd is ₹ 86.36 as of 18 Jul 15:30.
  • The P/E Ratio of Mangalam Drugs and Organics Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Medicamen Biotech Ltd changed from 16.6 on March 2020 to 44.5 on March 2024 . This represents a CAGR of 21.80% over 5 years.
  • The Market Cap of Mangalam Drugs and Organics Ltd changed from ₹ 146.65 crore on March 2024 to ₹ 146.65 crore on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Medicamen Biotech Ltd changed from ₹ 220.75 crore on March 2020 to ₹ 487.1 crore on March 2024 . This represents a CAGR of 17.15% over 5 years.
  • The revenue of Mangalam Drugs and Organics Ltd for the Mar '25 is ₹ 73.25 crore as compare to the Dec '24 revenue of ₹ 88.85 crore. This represent the decline of -17.56% The revenue of Medicamen Biotech Ltd for the Mar '25 is ₹ 34.84 crore as compare to the Dec '24 revenue of ₹ 45.28 crore. This represent the decline of -23.06%.
  • The ebitda of Mangalam Drugs and Organics Ltd for the Mar '25 is ₹ 10.37 crore as compare to the Dec '24 ebitda of ₹ 8.91 crore. This represent the growth of 16.39% The ebitda of Medicamen Biotech Ltd for the Mar '25 is ₹ 3.62 crore as compare to the Dec '24 ebitda of ₹ 6.85 crore. This represent the decline of -47.15%.
  • The net profit of Mangalam Drugs and Organics Ltd changed from ₹ 0.5 crore to ₹ 0.06 crore over 6 quarters. This represents a CAGR of -75.67% The net profit of Medicamen Biotech Ltd changed from ₹ 3.95 crore to ₹ 1.86 crore over 8 quarters. This represents a CAGR of -31.38% .
  • The Dividend Payout of Mangalam Drugs and Organics Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Medicamen Biotech Ltd changed from 4.98 % on March 2020 to 9.56 % on March 2024 . This represents a CAGR of 13.93% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Mangalam Drugs and Organics Ltd

  • Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
  • The company was promoted by Dhoot family.
  • The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
  • The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

About Medicamen Biotech Ltd

  • A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets.
  • The Company has presence in 40+ countries.
  • Its offerings include Finished Dosage Forms (FDF's) to African countries. In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market.
  • MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan).
  • The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others.

Mangalam Drugs and Organics Ltd News Hub

News

Mangalam Drugs and Organics schedules EGM

Mangalam Drugs and Organics announced that an Extra Ordinary General Meeting (EGM) of the ...

Read more

14 Jul 2025 10:27

News

Mangalam Drugs and Organics announces board meeting date

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

15 May 2025 15:37

News

Mangalam Drugs and Organics to conduct board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

05 Apr 2025 10:36

News

Mangalam Drugs and Organics to convene board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

06 Feb 2025 16:48

News

Mangalam Drugs and Organics receives upgrade in credit ratings from CRISIL

Mangalam Drugs and Organics has received upgrade in credit ratings from CRISIL as under: L...

Read more

16 Jan 2025 14:54

News

Mangalam Drugs and Organics Ltd leads gainers in 'B' group

Soma Textiles & Industries Ltd, Saraswati Saree Depot Ltd, Pudumjee Paper Products Ltd and...

Read more

29 Nov 2024 12:15

Medicamen Biotech Ltd News Hub

News

Medicamen Biotech rallies after securing USFDA approval for Bortezomib injection

The ANDA pertains to Bortezomib for Injection, 3.5 mg single-dose vial. The USFDA has dete...

Read more

03 Jun 2025 13:07

News

Board of Medicamen Biotech recommends final dividend

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held...

Read more

31 May 2025 12:29

News

Medicamen Biotech to hold board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2...

Read more

23 May 2025 20:27

News

Medicamen Biotech to convene EGM

Medicamen Biotech announced that an Extra Ordinary General Meeting (EGM) of the Company wi...

Read more

27 Feb 2025 16:47

News

Medicamen Biotech announces board meeting date

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 26 Febru...

Read more

21 Feb 2025 19:50

News

Medicamen Biotech to declare Quarterly Results

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 11 Febru...

Read more

05 Feb 2025 14:45

SWOT Analysis Of Medicamen Biotech Ltd

Strength

4

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Mangalam Drugs and Organics Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Medicamen Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Mangalam Drugs and Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Mangalam Drugs and Organics Ltd and Medicamen Biotech Ltd

Which company has a larger market capitalization, Mangalam Drugs and Organics Ltd or Medicamen Biotech Ltd?

Market cap of Mangalam Drugs and Organics Ltd is 136 Cr while Market cap of Medicamen Biotech Ltd is 548 Cr

What are the key factors driving the stock performance of Mangalam Drugs and Organics Ltd and Medicamen Biotech Ltd?

The stock performance of Mangalam Drugs and Organics Ltd and Medicamen Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mangalam Drugs and Organics Ltd and Medicamen Biotech Ltd?

As of July 20, 2025, the Mangalam Drugs and Organics Ltd stock price is INR ₹86.36. On the other hand, Medicamen Biotech Ltd stock price is INR ₹404.2.

How do dividend payouts of Mangalam Drugs and Organics Ltd and Medicamen Biotech Ltd compare?

To compare the dividend payouts of Mangalam Drugs and Organics Ltd and Medicamen Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions